Pretax income is the income that a company earns before paying income taxes. AVITA Medical's pretax income for the
three
months ended in Dec. 2024 was $-11.57 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was $-61.79 Mil.
AVITA Medical's pretax margin was -62.86%.
During the past 13 years, AVITA Medical's highest Pretax Margin was -70.43%. The lowest was -1486.44%. And the median was -288.46%.
AVITA Medical Pre-Tax Income Historical Data
The historical data trend for AVITA Medical's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of AVITA Medical's Pre-Tax Income
For the Medical Devices subindustry, AVITA Medical's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AVITA Medical's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where AVITA Medical's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-61.79 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVITA Medical (NAS:RCEL) Pre-Tax Income Explanation
AVITA Medical's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as
During the past 13 years, AVITA Medical's highest Pretax Margin was -70.43%. The lowest was -1486.44%. And the median was -288.46%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVITA Medical Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of AVITA Medical's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RCEL has been successfully added to your 